Sex: M
Vaccine: COVID19-2
Symptoms: Circumstance or information capable of leading to medication error, Inappropriate schedule of product administration, No adverse event, Product storage error
Clinical narrative: The patient received his first Moderna Covid-19 monovalent vaccine booster dose on February 9, 2022 ,The patient received his first Moderna bivalent booster dose on February 13, 2022.; Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes.; Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received his first Moderna Covid-19 monovalent vaccine booster dose on February 9, 2022 ,The patient received his first Moderna bivalent booster dose on February 13, 2022.), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes.), PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes.) and NO ADVERSE EVENT (No adverse event) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7173B) for COVID-19 prophylaxis.     Patient had not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 21-Apr-2023, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received his first Moderna Covid-19 monovalent vaccine booster dose on February 9, 2022 ,The patient received his first Moderna bivalent booster dose on February 13, 2022.), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes.), PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes.) and NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received his first Moderna Covid-19 monovalent vaccine booster dose on February 9, 2022 ,The patient received his first Moderna bivalent booster dose on February 13, 2022.), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes.), PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient received his first Moderna Covid-19 monovalent vaccine booster dose on February 9, 2022 ,The patient received his first Moderna bivalent booster dose on February 13, 2022.), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes.) and PRODUCT STORAGE ERROR (Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes.).    No concomitant medications were reported.  Patient received the first dose of his Moderna Primary series on 07-Apr-2021,lot number 020B1A in left deltoid muscle, received second Moderna Primary Series dose on 05-May-2021 lot number 021C21A in left deltoid, then received first Moderna Covid-19 monovalent vaccine booster dose on 09-Feb-2022 with lot number 045L21A, then first Moderna bivalent booster dose on 13-Feb-2022. Lot number AS7162B with Left deltoid injection site. Patient received Moderna Covid-19 vaccine that had been left in a medical cooler with the temperature not monitored for 19 hours and 25 minutes. No treatment details were reported.